NMA

We are very happy to welcome Catarina Vitor as an analyst at NMA. Catarina has a Master’s degree in Pharmaceutical sciences (University of Lisbon) and a Master’s degree in Health economics, policy and management (Karolinska Institutet). She has …

We welcome Luca Bottazzi to NMA, our most recent addition to the analyst team. Luca holds a Master in Economics from Lund University and Bachelor in Economics from the University of Pavia.

We’re happy to welcome Therese Dibbern to NMA, our new Director of Health Economics and Outcome Research. Therese has a broad experience working in many different therapeutic areas and joins us most recently from Novartis …

We’re starting to come back from summer vacations and are happy to have additional support by Alexa Zamfir as an interim analyst. Alexa is a second year Masters student in Health economics at KI and …

We’re happy to welcome Inola to the growing NMA team! Inola is a medical doctor and completed her master’s degree in health economics, policy and management at Karolinska Institutet. She is excited to gain practical experience …

It’s a great feeling to be big enough to offer a promotion and yet still small enough for it to feel like something that we need to share with the world! Health economist Greta Bütepage …

After completing his Master’s in Bioentrepreneurship with a Master’s thesis on the Market Access situation for CAR-T therapies which he carried out at NMA, Jesús has now joined the team as a full-time analyst in …

Thank you all for a great collaboration in a year that has been very different. We look forward to continue providing you with the best market access support in 2021

Join a fast-growing Market Access consultancy with focus on the Nordics! We are looking both for entry-level analysts and more senior consultants to join us in Stockholm to help us solve our client’s Market Access …